共 48 条
[1]
Lopez AD(1998)The global burden of disease, 1990–2020 Nat Med 4 1241-3
[2]
Murray CC(2007)Fourth Joint European Societies’ Task Force on Cardiovascular Disease Prevention in Clinical Practice Eur J Cardiovasc Prev Rehabil 14 S1-113
[3]
Chambless L(1997)Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985–1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease Circulation 96 3849-59
[4]
Keil U(2001)Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators J Am Coll Cardiol 38 56-63
[5]
Dobson A(2001)Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment Eur Heart J 22 1119-27
[6]
Marschner IC(1997)European action on secondary prevention through intervention to reduce events. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results Eur Heart J 18 1569-82
[7]
Colquhoun D(2001)Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme Eur Heart J 22 554-95
[8]
Simes RJ(2003)Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort Eur J Cardiovasc Prev Rehabil 10 289-7
[9]
Wilhelmsen L(2007)Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP) Eur J Cardiovasc Prev Rehabil 14 532-52
[10]
Pyorala K(2007)Outcome after coronary artery bypass graft surgery, coronary angioplasty and stenting Int J Cardiol 116 46-64